Brief: Kane Biotech Qtrly Loss Per Share $0.008
25/03/2019 20:39
March 25 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018
FINANCIAL RESULTS
* KANE BIOTECH INC - QTRLY LOSS PER SHARE (POST
CONSOLIDATION)
$0.008
Source text for Eikon: ID:nGNX7Pfb3f
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update